Immediate Impact

1 from Science/Nature 62 standout
Sub-graph 1 of 24

Citing Papers

Acute lymphoblastic leukaemia
2024 Standout
Protein degraders enter the clinic — a new approach to cancer therapy
2023 Standout
2 intermediate papers

Works of Barbara Denys being referenced

Clinical implications of measurable residual disease in AML: Review of current evidence
2018
Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia
2012

Author Peers

Author Last Decade Papers Cites
Barbara Denys 146 74 34 83 22 276
John Bæch 101 65 39 35 20 292
F. C. de Waal 123 128 43 156 23 327
Sumita Saluja 91 79 54 152 19 300
Te‐Kau Chang 94 75 23 30 26 288
Eva Leinøe 210 34 18 9 28 312
Maria Lúcia de Martino Lee 73 72 65 104 19 285
Jen‐Yin Hou 100 81 66 91 25 247
Yasufumi Matsuda 62 91 69 18 26 251
Koichi Udagawa 58 60 36 59 15 251
Lorenza Borin 148 41 32 17 22 223

All Works

Loading papers...

Rankless by CCL
2026